Linked from

The 25 pages that link to Thrombocytopenia, each with the reason it gives.

• Complete blood countRelated: The platelet result can reveal thrombocytopenia, which may affect bleeding risk.

• HemostasisRelated: Too few platelets can prevent an adequate primary hemostatic plug.

• PlateletCompared with: Too few platelets can impair plug formation and increase bleeding risk.

• ThrombosisCompared with: Low platelet counts commonly increase bleeding risk, while thrombosis concerns inappropriate clot formation.

• Aplastic anemiaRelated: Platelet deficiency causes easy bruising, bleeding, and petechiae.

• Acute myeloid leukemiaRelated: Reduced platelet production in AML can cause bruising, nosebleeds, or serious hemorrhage.

• ValproateRelated: Valproate can lower platelet counts, particularly at higher drug concentrations.

• Acute lymphoblastic leukemiaRelated: Suppressed platelet production can lead to bruising and bleeding in ALL.

• MyelosuppressionBroader topic: Lower platelet production creates bleeding risk when marrow suppression affects megakaryocytes.

• Thrombotic thrombocytopenic purpuraNarrower topic: Platelet consumption in microthrombi produces the low count central to TTP.

• Hemolytic uremic syndromeBroader topic: Platelet consumption in small-vessel clots produces this core laboratory finding.

• Antiphospholipid syndromeRelated: It can accompany the syndrome despite its strong association with thrombosis.

• Gaucher diseaseRelated: Splenic enlargement and marrow involvement can contribute to low platelet counts.

• Thrombotic microangiopathyRelated: Platelet consumption produces a key laboratory feature of the syndrome.

• Rocky Mountain spotted feverRelated: Low platelet counts are a common laboratory finding as the disease progresses.

• ThrombophiliaCompared with: A low platelet count concerns platelet number and bleeding risk, not necessarily an inherited tendency to clot.

• CarboplatinRelated: Carboplatin can suppress bone marrow, making low platelet counts a dose-limiting toxicity.

• TemozolomideBroader topic: Temozolomide can suppress platelet production and require treatment interruption or dose adjustment.

• Wiskott–Aldrich syndromeBroader topic: The syndrome's platelet deficit reflects impaired platelet production and survival.

• Atypical hemolytic uremic syndromeRelated: Platelets are consumed in small-vessel thrombi, often lowering their circulating count.

• Blood cellRelated: A reduced platelet population can impair clotting and increase bleeding risk.

• Hemic and Lymphatic DiseasesBroader topic: It exemplifies a blood-cell disorder with direct effects on hemostasis.

• Immune thrombocytopenic purpuraNarrower topic: ITP is one immune-mediated cause of this broader laboratory finding.

• Jacobsen syndromeNarrower topic: Low platelet counts can contribute to bleeding in Jacobsen syndrome.

• NosebleedRelated: Low platelet counts can contribute to recurrent or persistent bleeding.